| 发明名称 |
PHARMACEUTICAL FORMULATION |
| 摘要 |
A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours. |
| 申请公布号 |
US2017100355(A1) |
申请公布日期 |
2017.04.13 |
| 申请号 |
US201615291061 |
申请日期 |
2016.10.11 |
| 申请人 |
Reckitt Benckiser LLC |
发明人 |
Cavatur Raghu;Chen Kevin;Kaser Matthew;Qiu Hongchun;Woodhouse Ernest Joseph;Borovicka Josef;Wilkinson Elliot |
| 分类号 |
A61K31/192;A61K9/24;A61K31/09;A61K31/485;A61K9/48;A61K9/20 |
主分类号 |
A61K31/192 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition comprising a pharmaceutically effective amount of each of guaifenesin, naproxen and dextromethorphan. |
| 地址 |
Parsippany NJ US |
